{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"tesamorelin-post-surgery","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-post-surgery/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/tesamorelin-post-surgery/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-post-surgery/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-post-surgery/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-post-surgery/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-post-surgery/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-post-surgery/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"tesamorelin-post-surgery","title":"Tesamorelin for Post-Surgery Recovery: A Data-First Evidence Review","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:42:25.289Z","body_excerpt":"## What's breaking down\n\nPost-surgery recovery involves multiple layers of tissue response. Surgical trauma disrupts skin, muscle, fascia, nerves, and sometimes bone or tendon continuity. Inflammatory signals rise to clear debris. Then repair pathways activate to rebuild extracellular matrix, restore blood supply, and reconnect nerve endings if cut. Muscle can atrophy from disuse or denervation. Visceral fat accumulation may increase in some patients due to immobility, stress hormones, or changes in metabolism. If repair lags behind breakdown, scar tissue forms instead of functional tissue, strength returns slowly, and function stays limited. Growth hormone pathways influence several of these steps by supporting protein synthesis, collagen production, and cell proliferation in repair sites.\n\n## Why Tesamorelin might help you\n\nTesamorelin is a growth hormone-releasing hormone analog. It binds receptors in the pituitary to increase pulsatile growth hormone release, which in turn raises IGF-1 levels.\n\nTherefore for you: If the GH axis layer is part of your post-surgery problem, Tesamorelin is discussed because it targets repair pathways in tissue rather than masking pain or inflammation.\n\n1. Surgical injury reduces local growth factor signaling in some cases.\n2. Raising GH and IGF-1 may support satellite cell activity and protein synthesis in muscle and connective tissue.\n3. This could favor organized collagen deposition over disorganized scar in animal models of nerve and muscle injury.\n4. Visceral fat reduction seen in other contexts might ease mechanical stress on healing abdominal or spinal sites indirectly.\n5. The net effect discussed is shifting the balance toward regeneration instead of prolonged degeneration.\n\n## How these fit together\n\nSingle-compound focus. Tesamorelin addresses the GH axis and visceral fat layer. If your post-surgery profile includes other degeneration layers such as direct inflammation or nerve-specific damage, other compounds would target those separately without overlap in this review.\n\n## What the evidence actually shows\n\nHuman data come from phase 3 randomized, double-blind, placebo-controlled trials in HIV patients with excess abdominal fat. Two multicenter trials (LIPO-010 and CTR-1011) randomized over 800 participants to 2 mg daily tesamorelin or placebo for 26 weeks. Primary outcome was visceral adipose tissue reduction measured by CT or MRI. Pooled analysis showed statistically significant VAT decrease that was maintained in extension phases up to 52 weeks, with preservation of subcutaneous fat and improvements in body image scores. A separate smaller RCT found modest liver fat reduction. These trials establish human evidence for VAT reduction and IGF-1 elevation but enrolled no post-surgical patients and measured no wound healing or functional recovery endpoints.\n\nPreclinical data include animal studies on growth hormone effects after peripheral nerve injury. One research proposal references rodent models showing GH accelerates axonal regeneration and reduces muscle atrophy after nerve transection and repair. A planned human trial (PR212195) tests tesamorelin after peripheral nerve injury repair for motor and sensory outcomes, but results are not yet available. No completed human RCTs exist for tesamorelin in post-surgical wound healing, muscle recovery, or general surgical patients.\n\nAnecdotal reports appear on forums but remain unverified.\n\n## What scientists say\n\nPublished reviews note tesamorelin reliably lowers visceral fat via GH stimulation in specific populations. Authors emphasize the compound's selectivity for visceral over subcutaneous fat and its FDA approval status for HIV lipodystrophy. They highlight lack of data outside that indication and call for studies in other metabolic or recovery settings. Mechanistic papers link GH/IGF-1 to enhanced collagen synthesis and myogenesis but stress these pathways require further clinical validation in surgical contexts.\n\n## What people say","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c1","text":"Phase 3 RCTs in HIV patients showed tesamorelin reduced visceral adipose tissue compared with placebo over 26 weeks.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the primary human efficacy signal for the compound.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c3","text":"No completed human RCTs exist for tesamorelin in post-surgical wound healing or general recovery.","tier":"human","weight":0.8,"section":"What we do not know","slot":null,"interaction_risk":false,"status":"active","source_ids":[],"source_status":"unsourced","why_material":"Clarifies the evidence gap for the specific use case.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c2","text":"Animal studies suggest growth hormone can accelerate axonal regeneration and reduce muscle atrophy after nerve injury.","tier":"preclinical","weight":0.5,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s2"],"source_status":"sourced","why_material":"Provides mechanistic rationale discussed for post-surgical nerve repair.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c4","text":"Reddit users report subjective visceral fat loss and improved workout recovery with tesamorelin.","tier":"anecdotal","weight":0.3,"section":"What people say on Reddit","slot":null,"interaction_risk":false,"status":"active","source_ids":["s3"],"source_status":"sourced","why_material":"Documents real-world discussion separate from trials.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c5","text":"A planned clinical trial will test tesamorelin after peripheral nerve injury repair.","tier":"speculative","weight":0.1,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s2"],"source_status":"sourced","why_material":"Indicates ongoing research direction.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.1,"quote_gated":true}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/20554713/","title":"Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials","quote":"Treatment with tesamorelin reduces VAT and maintains the reduction for up to 52 wk","summary":"Pooled phase 3 data showing VAT reduction in HIV patients.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"c4d52f7ecc29ee26c540d33bb56e2ade2c58d7647f1218fbeb9f69a84f8eaf87"},{"id":"s2","type":"other","url":"https://www.foundationforpn.org/wp-content/uploads/2025/01/Tesamorelin-Therapy-to-Enhance-Axonal-Regeneration-Minimize-Muscle-Atrophy-and-Improve-Functional-Outcomes-Following-Peripheral-Nerve-Injury-and-Repair.pdf","title":"Tesamorelin Therapy to Enhance Axonal Regeneration... Following Peripheral Nerve Injury and Repair","quote":"animal studies have shown that growth hormone, via its downstream factors, can speed peripheral nerve regeneration following injury and can directly act on muscle to prevent atrophy","summary":"Grant proposal citing preclinical nerve injury data and describing planned trial.","claim_ids":["c2","c5"],"link_status":"ok","quote_status":"unverified","hash":"c737de4c664b4318db092977335a499631e5e64cdf17e8d3775e54d9489bd647"},{"id":"s3","type":"reddit","url":"https://www.reddit.com/r/Biohackers/comments/1qlnwf7/starting_tesamorelin_next_week_advice_needed/","title":"Starting Tesamorelin next week. Advice needed","quote":"Tesamorelin can be effective for leaning out and supporting lean muscle when combined with regular exercise.","summary":"User discussion on body composition and recovery effects.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"b26b2a772e3a60fe0cb8966b05f46fc16f72d8f0f8e70dc10bb7294011a56f19"}],"anecdotal_sources":[{"id":"s3","type":"reddit","url":"https://www.reddit.com/r/Biohackers/comments/1qlnwf7/starting_tesamorelin_next_week_advice_needed/","title":"Starting Tesamorelin next week. Advice needed","quote":"Tesamorelin can be effective for leaning out and supporting lean muscle when combined with regular exercise.","summary":"User discussion on body composition and recovery effects.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"b26b2a772e3a60fe0cb8966b05f46fc16f72d8f0f8e70dc10bb7294011a56f19"}],"scientific_sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/20554713/","title":"Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials","quote":"Treatment with tesamorelin reduces VAT and maintains the reduction for up to 52 wk","summary":"Pooled phase 3 data showing VAT reduction in HIV patients.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"c4d52f7ecc29ee26c540d33bb56e2ade2c58d7647f1218fbeb9f69a84f8eaf87"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"tesamorelin-post-surgery","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":5,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":5,"claims_total":5,"sources":3,"anecdotal":1,"scientific":1,"user_reports":0,"questions":0,"evidence_ingests":0}}